For many years, UCB has responded to changing needs for better health care. Our medicines aim to bring longer lives and healthier living to people all over the world.
Our medicines are also tackling the effects of serious central nervous system (CNS) and immunological diseases.
Our scientists are continuing to seek new solutions to the challenges that are facing today's health care providers.
UCB in the U.S. focuses on severe diseases in the following areas: central nervous system, immunology and allergy/respiratory disorders.